CYTOSORBENTS CORPORATION Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
CYTOSORBENTS CORPORATION (CTSO) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $4.13 per share as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2026-03-30
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.13.
- 2025-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.14.
- 2025-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.24.
- 2025-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.98.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $4.13 10-K · filed 2026-03-30 |
| 2025-09-30 | $4.14 10-Q · filed 2025-11-13 |
| 2025-06-30 | $4.24 10-Q · filed 2025-08-07 |
| 2025-03-31 | $4.98 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.46 10-K · filed 2025-03-31 |
| 2024-09-30 | $5.48 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.91 10-Q · filed 2024-08-13 |
| 2024-03-31 | $5.88 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.97 10-K · filed 2024-03-15 |
| 2023-09-30 | $5.88 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.14 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.03 10-Q · filed 2023-05-02 |
| 2022-12-31 | $6.32 10-K · filed 2023-03-09 |
| 2022-09-30 | $6.36 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.52 10-Q · filed 2022-08-02 |
| 2022-03-31 | $6.46 10-Q · filed 2022-05-03 |
| 2021-12-31 | $6.45 10-K · filed 2022-03-10 |
| 2021-09-30 | $6.42 10-Q · filed 2021-11-04 |
| 2021-06-30 | $6.37 10-Q · filed 2021-08-03 |
| 2021-03-31 | $6.26 10-Q · filed 2021-05-04 |
| 2020-12-31 | $6.18 10-K · filed 2021-03-09 |
| 2020-09-30 | $6.15 10-Q · filed 2020-11-04 |
| 2020-06-30 | $6.51 10-Q · filed 2020-08-04 |
| 2020-03-31 | $5.90 10-Q · filed 2020-05-05 |
| 2019-12-31 | $5.74 10-K · filed 2020-03-05 |
| 2019-09-30 | $5.68 10-Q · filed 2019-11-05 |
| 2019-06-30 | $5.50 10-Q · filed 2019-08-06 |
| 2019-03-31 | $5.36 10-Q · filed 2019-05-07 |
| 2018-12-31 | $4.96 10-K · filed 2019-03-07 |
| 2018-09-30 | $4.82 10-Q · filed 2018-11-06 |
| 2018-06-30 | $4.73 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.55 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.30 10-K · filed 2018-03-08 |
| 2017-09-30 | $4.31 10-Q · filed 2017-11-09 |
| 2017-06-30 | $4.28 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.26 10-Q · filed 2017-05-08 |
| 2016-12-31 | $4.63 10-K · filed 2017-03-03 |
| 2014-12-31 | $5.80 10-K · filed 2015-03-31 |
| 2013-12-31 | $0.23 10-K · filed 2014-03-31 |
| 2012-12-31 | $0.26 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |